TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
---|---|---|---|---|---|
2022 | USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1 | Cells | 7.607 | 36291159 | |
2022 | 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside ameliorates bleomycin-induced pulmonary fibrosis via regulating pro-fibrotic signaling pathways | Frontiers in Pharmacology | 5.988 | 36267283 | |
2022 | Boosting the detection performance of severe acute respiratory syndrome coronavirus 2 test through a sensitive optical biosensor with new superior antibody | Bioengineering Translational Medicine | 10.684 | 36248235 | |
2022 | Suramin enhances chondrogenic properties by regulating the p67phox/PI3K/AKT/SOX9 signalling pathway | Bone Joint Res. | 5.853 | 36222195 | |
2022 | Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma | International Immunopharmacology | 5.714 | 36183678 | |
2022 | The CHST11 gene is linked to lung cancer and pulmonary fibrosis | The Journal og Gene Medicine | 4.152 | 36181245 | |
2022 | MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS | European Journal of Pharmacology | 5.195 | 36174668 | |
2022 | The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2 | Biomedicine & Pharmacotherapy | 7.419 | 36081287 | |
2022 | The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs | Biomedicine & Pharmacotherapy | 7.419 | 36068781 |